|
LGQLQPSLQTGSEELRSLYN
|
Gag(61-80)
|
human epitope
|
QLQPSLQTGSEELRSLY
|
Gag(63-79)
|
human epitope
|
PAIQTGSEELRSLYNTVA
|
Gag(66-83)
|
human epitope
|
ALKTGTEELRSLYNT
|
Gag(67-81)
|
human epitope
|
ALqTGTEELkSLYNT
|
Gag(67-81)
|
susceptible form
|
ALQTGTEELKSLYNT
|
Gag(67-81)
|
human epitope
|
ALkTGTEELrSLYNT
|
Gag(67-81)
|
susceptible form
|
QTGSEELRSLYNTVATLYCVHQRIE
|
Gag(69-93)
|
A2 human epitope
|
TGTEELRSLYNTVATLY
|
Gag(70-86)
|
C*14 human epitope
|
TGSEELRSLYNTVATLY
|
Gag(70-86)
|
human epitope
|
TGSEELRSLYNTVATLY
|
Gag(70-86)
|
human epitope
|
GSEELRSLY
|
Gag(71-79)
|
A*01 human epitope
|
GSEELRSLY
|
Gag(71-79)
|
A*01 human epitope
|
GSEELkSLY
|
Gag(71-79)
|
|
GSEELRSLf
|
Gag(71-79)
|
|
GSEELRSLY
|
Gag(71-79)
|
A*01 human epitope
|
GSEELkSLY
|
Gag(71-79)
|
escape documented in this paper; observed variant
|
GSaELRSLY
|
Gag(71-79)
|
escape documented in this paper; observed variant
|
GSEELRSLf
|
Gag(71-79)
|
escape documented in this paper; observed variant
|
GSEELRSLY
|
Gag(71-79)
|
A*01 human epitope
|
GSEELRSLY
|
Gag(71-79)
|
A*01 human epitope
|
GSEELRSLY
|
Gag(71-79)
|
A*01 epitope
|
GSEELRSLY
|
Gag(71-79)
|
A*01 human epitope
|
GSEELRSLf
|
Gag(71-79)
|
escape documented in this paper
|
GSEELRSLc
|
Gag(71-79)
|
inferred escape
|
GSEELKSLY
|
Gag(71-79)
|
A*01 human epitope
|
GSEELrSLY
|
Gag(71-79)
|
susceptible form
|
GSEELRSLY
|
Gag(71-79)
|
A*01:01 human epitope
|
GSEEikSLY
|
Gag(71-79)
|
diminished HLA binding or increased off-rate; escape documented in this paper
|
GTEELRSLY
|
Gag(71-79)
|
A*01:01 human epitope
|
GSEELRSLY
|
Gag(71-79)
|
A*01:01 human epitope
|
GTEELRSLY
|
Gag(71-79)
|
A*01:01 human epitope
|
GTEELRSLf
|
Gag(71-79)
|
diminished HLA binding or increased off-rate; escape documented in this paper
|
GSEELRSLY
|
Gag(71-79)
|
A*01:01, B*57 human epitope
|
GSEELRSLY
|
Gag(71-79)
|
A1 human epitope
|
GSEELRSLY
|
Gag(71-79)
|
A1 human epitope
|
GSEELRSLY
|
Gag(71-79)
|
A1 human epitope
|
GtEgikSLh
|
Gag(71-79)
|
observed variant
|
GSEELRSLY
|
Gag(71-79)
|
A1 human epitope
|
GSEELRSLY
|
Gag(71-79)
|
A1 human epitope
|
GSEELRSLY
|
Gag(71-79)
|
A1 epitope
|
GSEELRSLY
|
Gag(71-79)
|
A1 human epitope
|
GSEELRSLY
|
Gag(71-79)
|
A1 human epitope
|
GSEELRSLY
|
Gag(71-79)
|
A1 human epitope
|
GSEELRSLY
|
Gag(71-79)
|
B*07 human epitope
|
GSEELRSLY
|
Gag(71-79)
|
C*14 human epitope
|
GSEELRSLY
|
Gag(71-79)
|
human epitope
|
GSEELRSLY
|
Gag(71-79)
|
human epitope
|
GSEELRSLY
|
Gag(71-79)
|
human epitope
|
GTEELKSLY
|
Gag(71-79)
|
human epitope
|
GTEELRSLY
|
Gag(71-79)
|
human epitope
|
GSEELRSLYNTVATL
|
Gag(71-85)
|
human epitope
|
GSEELRSLYNTVATL
|
Gag(71-85)
|
human epitope
|
GSEELKSLYNTVATL
|
Gag(71-85)
|
human epitope
|
GSEELRSLYNTVATLYCVHQ
|
Gag(71-90)
|
human epitope
|
GSEELRSLYNTVATLYCVHQ
|
Gag(71-90)
|
human epitope
|
EELRSLYNT
|
Gag(73-81)
|
human epitope
|
EELRSLYNTV
|
Gag(73-82)
|
B*40:06 human epitope
|
EELRSLYNTVATLYC
|
Gag(73-87)
|
A2 human epitope
|
EELKSLFNTIAVLWCVHQ
|
Gag(73-90)
|
human epitope
|
EELKSLFNTvAVLWCVHk
|
Gag(73-90)
|
observed variant
|
EELKSLFNTvAVLWCVHQ
|
Gag(73-90)
|
observed variant
|
EELKSLFNTvAVLcCVHQ
|
Gag(73-90)
|
observed variant
|
EELKpLFNTvAVLcCVHQ
|
Gag(73-90)
|
observed variant
|
EELRSLYNTVATLYCVHQ
|
Gag(73-90)
|
human epitope
|
ELRSLYNTV
|
Gag(74-82)
|
A*24 human epitope
|
ELRSLYNTV
|
Gag(74-82)
|
B*08 human epitope
|
ELKSLYNTV
|
Gag(74-82)
|
B*08 human epitope
|
ELrSLYNTV
|
Gag(74-82)
|
susceptible form
|
ELRSLYNTV
|
Gag(74-82)
|
B*08 human epitope
|
ELRSLYNTV
|
Gag(74-82)
|
B*08 human epitope
|
ELRSLYNTi
|
Gag(74-82)
|
observed variant
|
ELRSLfNTi
|
Gag(74-82)
|
observed variant
|
ELRSLcNTi
|
Gag(74-82)
|
observed variant
|
ELRSLYNai
|
Gag(74-82)
|
observed variant
|
ELRSLYNTV
|
Gag(74-82)
|
B*08 human epitope
|
ELRSLYNTV
|
Gag(74-82)
|
B*08 epitope
|
ELRSLYNTV
|
Gag(74-82)
|
B*08:01 human epitope
|
ELRSLYNTV
|
Gag(74-82)
|
B*08:01 human epitope
|
ELRSLYNTV
|
Gag(74-82)
|
B*08:01 human epitope
|
EiRSLYNTV
|
Gag(74-82)
|
observed variant
|
ELRSLYNaV
|
Gag(74-82)
|
observed variant
|
ELRSLYNTV
|
Gag(74-82)
|
B*40 human epitope
|
ELRSLYNTV
|
Gag(74-82)
|
B*52 human epitope
|
ELRSLYNTV
|
Gag(74-82)
|
B8 human epitope
|
ELKSLFNTI
|
Gag(74-82)
|
B8 human epitope
|
ELRSLYNTV
|
Gag(74-82)
|
B8 human epitope
|
ELRSLYNTV
|
Gag(74-82)
|
B8 human epitope
|
gikSLhNTV
|
Gag(74-82)
|
observed variant
|
ELRSLYNTV
|
Gag(74-82)
|
B8 human epitope
|
ELkSLYNTV
|
Gag(74-82)
|
observed variant
|
ELkSLYNTi
|
Gag(74-82)
|
inferred escape
|
ELkSLfNTV
|
Gag(74-82)
|
observed variant
|
ELKSLyNTV
|
Gag(74-82)
|
reversion
|
ELRSLYNTV
|
Gag(74-82)
|
B8 human epitope
|
ELRSLYNTV
|
Gag(74-82)
|
B8 human epitope
|
ELRSLYNTV
|
Gag(74-82)
|
B8 epitope
|
ELRSLYNTV
|
Gag(74-82)
|
B8 human epitope
|
ELRSLYNTV
|
Gag(74-82)
|
B8 human epitope
|
ELRSLYNTV
|
Gag(74-82)
|
C*06 human epitope
|
ELRSLYNTV
|
Gag(74-82)
|
human epitope
|
ELRSLYNTV
|
Gag(74-82)
|
human epitope
|
ELRSLYNTV
|
Gag(74-82)
|
human epitope
|
ELRSLYNTVA
|
Gag(74-83)
|
A2 human epitope
|
ELKSLYNTVATLYCV
|
Gag(74-88)
|
human epitope
|
ELrSLfNTVATLYCV
|
Gag(74-88)
|
subtype-specific susceptible form
|
eELrSLYNTVATLYCV
|
Gag(74-88)
|
subtype-specific susceptible form
|
ELrSLYNTVATLYCV
|
Gag(74-88)
|
subtype-specific susceptible form
|
LKSLfNTVATLYCVH
|
Gag(74-88)
|
subtype-specific susceptible form
|
RSLYNTVATLY
|
Gag(76-86)
|
A*02 human epitope
|
RSLYNTVATLY
|
Gag(76-86)
|
A*02:01, A*30:02 human epitope
|
RSLYNTiATLY
|
Gag(76-86)
|
diminished response; escape documented in this paper
|
RSLYNTVAvLY
|
Gag(76-86)
|
diminished response; escape documented in this paper
|
RSLYNTiAvLY
|
Gag(76-86)
|
diminished HLA binding or increased off-rate; diminished response; escape documented in this paper
|
RSLfNTiATLY
|
Gag(76-86)
|
diminished HLA binding or increased off-rate; diminished response; escape documented in this paper
|
RSLfNTVATLY
|
Gag(76-86)
|
diminished HLA binding or increased off-rate; diminished response; escape documented in this paper
|
RSLfNTVAvLY
|
Gag(76-86)
|
diminished HLA binding or increased off-rate; diminished response; escape documented in this paper
|
RSLfNTiAvLY
|
Gag(76-86)
|
diminished HLA binding or increased off-rate; diminished response; escape documented in this paper
|
kSLYNTVATLY
|
Gag(76-86)
|
diminished HLA binding or increased off-rate; diminished response
|
kSLYNTVAvLY
|
Gag(76-86)
|
diminished HLA binding or increased off-rate; diminished response; escape documented in this paper
|
kSLYNTiATLY
|
Gag(76-86)
|
diminished response; escape documented in this paper
|
kSLYNTiAvLY
|
Gag(76-86)
|
diminished HLA binding or increased off-rate; diminished response; escape documented in this paper
|
kSLfNTVATLY
|
Gag(76-86)
|
diminished HLA binding or increased off-rate; diminished response; escape documented in this paper
|
kSLfNTiATLY
|
Gag(76-86)
|
diminished HLA binding or increased off-rate; diminished response; escape documented in this paper
|
kSLfNTVAvLY
|
Gag(76-86)
|
diminished HLA binding or increased off-rate; diminished response; escape documented in this paper
|
kSLfNTiAvLY
|
Gag(76-86)
|
diminished HLA binding or increased off-rate; diminished response; escape documented in this paper
|
RSLYNTVATLY
|
Gag(76-86)
|
A*29 human epitope
|
RSLYNTiATLY
|
Gag(76-86)
|
observed variant
|
kSLfNTVATLY
|
Gag(76-86)
|
observed variant
|
kSLfNTVATLc
|
Gag(76-86)
|
observed variant
|
kSLYNTVAvLY
|
Gag(76-86)
|
observed variant
|
RSLYNTVATLY
|
Gag(76-86)
|
A*29 human epitope
|
RSLYNTVATLY
|
Gag(76-86)
|
A*30 human epitope
|
kSLYNTiATLY
|
Gag(76-86)
|
observed variant
|
kSLYNTVATLY
|
Gag(76-86)
|
observed variant
|
RSLfNTVATLY
|
Gag(76-86)
|
observed variant
|
RSLYNTVATLY
|
Gag(76-86)
|
A*30 human epitope
|
RSLYNTVATLY
|
Gag(76-86)
|
A*30 human epitope
|
RSLfNTVATLY
|
Gag(76-86)
|
observed variant
|
kSLYNTVATLY
|
Gag(76-86)
|
literature escape
|
RSLYNTVAvLY
|
Gag(76-86)
|
observed variant
|
RSLYNTiATLY
|
Gag(76-86)
|
observed variant
|
RSLYNTVvTLY
|
Gag(76-86)
|
observed variant
|
RSLYNTVATLY
|
Gag(76-86)
|
A30 human epitope
|
RSLYNTVAVLY
|
Gag(76-86)
|
A30 human epitope
|
RSLYNTVATLY
|
Gag(76-86)
|
A30 human epitope
|
RSLYNTVATLY
|
Gag(76-86)
|
A30 human epitope
|
RSLYNTATLY
|
Gag(76-86)
|
A30 human epitope
|
RSLYNTVATLY
|
Gag(76-86)
|
A30 human epitope
|
RSLYNTVATLY
|
Gag(76-86)
|
A30 human epitope
|
RSLYNTVATLY
|
Gag(76-86)
|
A30 epitope
|
RSLYNTVATLY
|
Gag(76-86)
|
A30 human epitope
|
RSLYNTVATLY
|
Gag(76-86)
|
A*30:02 human epitope
|
RSLYNTVATLY
|
Gag(76-86)
|
A*30:02 human epitope
|
RSLYNTVATLY
|
Gag(76-86)
|
A*30:02 human epitope
|
RSLYNTVATLY
|
Gag(76-86)
|
A*30:02 human, macaque epitope
|
RSLYNTVATLc
|
Gag(76-86)
|
escape documented in this paper
|
kSLfNTVATLc
|
Gag(76-86)
|
escape documented in this paper
|
RSLfNTiATLf
|
Gag(76-86)
|
escape documented in this paper
|
RLSYNTVATLY
|
Gag(76-86)
|
A*30:02 human epitope
|
RSLYNTVATLY
|
Gag(76-86)
|
A*30:02 human epitope
|
RSLYNTVATLY
|
Gag(76-86)
|
A*30:02 human epitope
|
RSLYNTVATLY
|
Gag(76-86)
|
A*30:02 human epitope
|
kSLYNTVATLY
|
Gag(76-86)
|
inferred escape
|
kSLYNTVAvLY
|
Gag(76-86)
|
inferred escape
|
RSLYNTVATLY
|
Gag(76-86)
|
A*30:02 human epitope
|
RSLfNTVATLY
|
Gag(76-86)
|
observed variant
|
RSLYNTVATLY
|
Gag(76-86)
|
A*30:02 human epitope
|
RSLYNTVATLY
|
Gag(76-86)
|
A*30:02 human epitope
|
RSLYNTVATLY
|
Gag(76-86)
|
A*30:02 human epitope
|
RSLYNTVATLY
|
Gag(76-86)
|
B57, B58, B63 human epitope
|
RSLYNTVATLY
|
Gag(76-86)
|
B*58 human epitope
|
RSLYNTVATLY
|
Gag(76-86)
|
B*63 human epitope
|
RSLYNTVATLY
|
Gag(76-86)
|
C*03 human epitope
|
RSLYNTVATLY
|
Gag(76-86)
|
human epitope
|
RSLYNTVATLY
|
Gag(76-86)
|
human epitope
|
RSLFNTVATLY
|
Gag(76-86)
|
human epitope
|
RSLyNTVATLY
|
Gag(76-86)
|
observed variant
|
RSLYNTVATLY
|
Gag(76-86)
|
human epitope
|
KSLYNTVVTLWCVHQ
|
Gag(76-90)
|
human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTIATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLfNTVAvL
|
Gag(77-85)
|
diminished response
|
SLvNTiATL
|
Gag(77-85)
|
diminished response
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLfNTiAvL
|
Gag(77-85)
|
escape documented in this paper
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTiATL
|
Gag(77-85)
|
susceptible form
|
SLfNTiATL
|
Gag(77-85)
|
diminished response; escape documented in this paper
|
SLYNaiATL
|
Gag(77-85)
|
inferred escape
|
SLcNTiATL
|
Gag(77-85)
|
inferred escape
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTVAvL
|
Gag(77-85)
|
HLA association; processing
|
SLfNTVATL
|
Gag(77-85)
|
HLA association; processing
|
SLYNTiATL
|
Gag(77-85)
|
HLA association; processing
|
SLYNTiAvL
|
Gag(77-85)
|
HLA association; processing
|
SLfNTiATL
|
Gag(77-85)
|
HLA association; processing
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLFNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02 epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTVAvL
|
Gag(77-85)
|
subtype-specific susceptible form
|
SLfNTVATL
|
Gag(77-85)
|
subtype-specific susceptible form
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTiATL
|
Gag(77-85)
|
susceptible form
|
SLfNTVATL
|
Gag(77-85)
|
susceptible form
|
SLfNTVAvL
|
Gag(77-85)
|
susceptible form
|
SLfNTiAvL
|
Gag(77-85)
|
susceptible form
|
SLhNTVATL
|
Gag(77-85)
|
escape documented in this paper; TCR related mutation
|
SLYaaaAaL
|
Gag(77-85)
|
susceptible form
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLFNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLFNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02 human epitope
|
SLFNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTIATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTIAvL
|
Gag(77-85)
|
susceptible form
|
SLYNTvATL
|
Gag(77-85)
|
susceptible form
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human, transgenic mouse epitope
|
SLFNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLFNTVAAL
|
Gag(77-85)
|
diminished response
|
SLFNTVATP
|
Gag(77-85)
|
diminished response
|
SLFSTVATL
|
Gag(77-85)
|
observed variant
|
SLFNTIATL
|
Gag(77-85)
|
susceptible form
|
SLYNTVATL
|
Gag(77-85)
|
susceptible form
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTiAvL
|
Gag(77-85)
|
literature escape
|
SLfNTVATL
|
Gag(77-85)
|
literature escape
|
SLYNTiATL
|
Gag(77-85)
|
literature escape
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human, transgenic mouse epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 transgenic mouse epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLfNTVATL
|
Gag(77-85)
|
observed variant
|
SLYNTiAvL
|
Gag(77-85)
|
observed variant
|
SLYNpiAvL
|
Gag(77-85)
|
observed variant
|
SLYNTiATL
|
Gag(77-85)
|
observed variant
|
SLYNTVAaL
|
Gag(77-85)
|
observed variant
|
SLYNTVAvL
|
Gag(77-85)
|
observed variant
|
SLYNTVtvL
|
Gag(77-85)
|
observed variant
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLFNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVAAL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 humanized mouse epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 transgenic mouse epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLfNTVATL
|
Gag(77-85)
|
observed variant
|
SLYNTVATi
|
Gag(77-85)
|
observed variant
|
SLYNTVAvL
|
Gag(77-85)
|
observed variant
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLfNaiAvL
|
Gag(77-85)
|
subtype-specific non-susceptible form
|
SLfNTVATL
|
Gag(77-85)
|
subtype-specific non-susceptible form
|
SLYNTiATL
|
Gag(77-85)
|
subtype-specific susceptible form
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVVTL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVaTL
|
Gag(77-85)
|
susceptible form
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLFNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLyNTVATL
|
Gag(77-85)
|
subtype-specific non-susceptible form
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLfNTVATL
|
Gag(77-85)
|
susceptible form
|
SLYNTiATL
|
Gag(77-85)
|
susceptible form
|
SLfNTiATL
|
Gag(77-85)
|
susceptible form
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVAvL
|
Gag(77-85)
|
diminished HLA binding or increased off-rate; escape documented in this paper; literature escape; susceptible form
|
{k}SLfNTVAvL
|
Gag(77-85)
|
literature escape
|
{k}SLfNTiAvL
|
Gag(77-85)
|
literature escape
|
{k}SLYNTVATL
|
Gag(77-85)
|
literature escape
|
SLfNTVATL
|
Gag(77-85)
|
escape documented in this paper; literature escape; susceptible form
|
{k}SLfNTiATL
|
Gag(77-85)
|
literature escape
|
{k}SLfNTVATL
|
Gag(77-85)
|
literature escape
|
SLYNTiATL
|
Gag(77-85)
|
diminished HLA binding or increased off-rate; diminished response; escape documented in this paper; literature escape; susceptible form
|
SLYNTiAvL
|
Gag(77-85)
|
diminished HLA binding or increased off-rate; escape documented in this paper; literature escape; susceptible form
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLfNTiATL
|
Gag(77-85)
|
subtype-specific non-susceptible form; subtype-specific susceptible form
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLhNaVAvL
|
Gag(77-85)
|
escape documented in this paper
|
SLfNTVATL
|
Gag(77-85)
|
escape documented in this paper
|
SLYNTiAvL
|
Gag(77-85)
|
susceptible form
|
SLhNTVATL
|
Gag(77-85)
|
escape documented in this paper
|
SLlNTVATL
|
Gag(77-85)
|
observed variant
|
SLYNTVAvL
|
Gag(77-85)
|
observed variant
|
SLYNTiATL
|
Gag(77-85)
|
observed variant
|
SLsNTiATL
|
Gag(77-85)
|
observed variant
|
SLfNTVAvL
|
Gag(77-85)
|
observed variant
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLfNTVATL
|
Gag(77-85)
|
escape documented in this paper; susceptible form
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 humanized mouse epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 mouse epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLfNTVATL
|
Gag(77-85)
|
subtype-specific susceptible form
|
SLYNTiaTL
|
Gag(77-85)
|
subtype-specific susceptible form
|
SLYNIiAvL
|
Gag(77-85)
|
subtype-specific susceptible form
|
SLYNTVAvL
|
Gag(77-85)
|
subtype-specific susceptible form
|
SLfNTiATL
|
Gag(77-85)
|
subtype-specific susceptible form
|
SLfNTiAvL
|
Gag(77-85)
|
subtype-specific susceptible form
|
SLfNTVAvL
|
Gag(77-85)
|
subtype-specific susceptible form
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLfNTVATL
|
Gag(77-85)
|
diminished HLA binding or increased off-rate; escape documented in this paper
|
SLfNTVAvL
|
Gag(77-85)
|
escape documented in this paper; TCR related mutation
|
SLYNTVvTL
|
Gag(77-85)
|
inferred escape
|
SLfNTiATL
|
Gag(77-85)
|
inferred escape
|
SLYNTiAvL
|
Gag(77-85)
|
escape documented in this paper; TCR related mutation
|
SLhNTVAvL
|
Gag(77-85)
|
diminished HLA binding or increased off-rate; escape documented in this paper
|
SLYNTVAvL
|
Gag(77-85)
|
diminished HLA binding or increased off-rate; escape documented in this paper
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 mouse epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 epitope
|
SLfNTVATL
|
Gag(77-85)
|
susceptible form
|
SLYNTiATL
|
Gag(77-85)
|
susceptible form
|
SLYNTVAvL
|
Gag(77-85)
|
susceptible form
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTiATL
|
Gag(77-85)
|
escape documented in this paper; processing; susceptible form
|
SvYNTVATL
|
Gag(77-85)
|
escape documented in this paper; processing; susceptible form
|
SLYNlVATL
|
Gag(77-85)
|
escape documented in this paper; processing; susceptible form
|
SLfNTVAvL
|
Gag(77-85)
|
escape documented in this paper; processing; susceptible form
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 mouse epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 mouse epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 humanized mouse epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLfNTVATL
|
Gag(77-85)
|
diminished HLA binding or increased off-rate
|
SLYNTVAvL
|
Gag(77-85)
|
diminished HLA binding or increased off-rate
|
SLYNTiATL
|
Gag(77-85)
|
diminished HLA binding or increased off-rate
|
SLfNTiAvL
|
Gag(77-85)
|
diminished HLA binding or increased off-rate; literature escape
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
{l}SLYNTVAvL
|
Gag(77-85)
|
observed variant
|
{l}SLYNTVATL
|
Gag(77-85)
|
susceptible form
|
{m}SLYNTVATL
|
Gag(77-85)
|
observed variant
|
SLYNaVAvL
|
Gag(77-85)
|
non-susceptible form
|
{m}SLYNTVAvL
|
Gag(77-85)
|
observed variant
|
{i}SLYNTVATL
|
Gag(77-85)
|
observed variant
|
aLYNTVAvL
|
Gag(77-85)
|
observed variant
|
aLfNTVATL
|
Gag(77-85)
|
observed variant
|
SLYNiVATL
|
Gag(77-85)
|
observed variant
|
{q}SLYNTVAvL
|
Gag(77-85)
|
observed variant
|
{q}SLYNTVATL
|
Gag(77-85)
|
observed variant
|
{v}SLYNTVATL
|
Gag(77-85)
|
observed variant
|
SLYNcVATL
|
Gag(77-85)
|
observed variant
|
{t}SLYNTVATL
|
Gag(77-85)
|
observed variant
|
SLYNTiAsL
|
Gag(77-85)
|
observed variant
|
SLYNsVAvL
|
Gag(77-85)
|
observed variant
|
SLYNciATL
|
Gag(77-85)
|
observed variant
|
aLYNTVATL
|
Gag(77-85)
|
observed variant
|
SLYNTVAvL
|
Gag(77-85)
|
observed variant
|
SLYNlVATL
|
Gag(77-85)
|
observed variant
|
{t}SLYNTVAvL
|
Gag(77-85)
|
observed variant
|
{v}SLYNTVAvL
|
Gag(77-85)
|
observed variant
|
SLYNTiAvL
|
Gag(77-85)
|
observed variant
|
{l}SLYNlVATL
|
Gag(77-85)
|
observed variant
|
{n}SLYNTVAvL
|
Gag(77-85)
|
observed variant
|
{f}SLYNTVATL
|
Gag(77-85)
|
observed variant
|
SLYNTiATL
|
Gag(77-85)
|
observed variant
|
SLYNTVAcL
|
Gag(77-85)
|
non-susceptible form
|
{l}SLYNTVAcL
|
Gag(77-85)
|
observed variant
|
{l}SLYNTVATL{w}
|
Gag(77-85)
|
observed variant
|
{c}SLYNTVATL
|
Gag(77-85)
|
observed variant
|
{k}SLYNTVATL
|
Gag(77-85)
|
observed variant
|
SLYNcVAcL
|
Gag(77-85)
|
non-susceptible form
|
SLYNTcAvL
|
Gag(77-85)
|
observed variant
|
SLYNTVAsL
|
Gag(77-85)
|
observed variant
|
SLfNTVATL
|
Gag(77-85)
|
observed variant
|
SLYNlVAvL
|
Gag(77-85)
|
observed variant
|
SLYNTVAaL
|
Gag(77-85)
|
observed variant
|
{m}SLYNlVATL
|
Gag(77-85)
|
observed variant
|
{v}SLYNlVATL
|
Gag(77-85)
|
observed variant
|
{h}SLYNTVATL
|
Gag(77-85)
|
observed variant
|
{a}SLYNTVATL
|
Gag(77-85)
|
observed variant
|
SLYNTVATL{c}
|
Gag(77-85)
|
observed variant
|
SLYNTVATL{f}
|
Gag(77-85)
|
observed variant
|
{v}SLYNTVATL{w}
|
Gag(77-85)
|
observed variant
|
{m}SLYNTVATL{w}
|
Gag(77-85)
|
observed variant
|
{w}SLYNTVATL
|
Gag(77-85)
|
observed variant
|
{s}SLYNTVATL
|
Gag(77-85)
|
observed variant
|
{n}SLYNTVATL
|
Gag(77-85)
|
observed variant
|
{a}aLYNTVATL
|
Gag(77-85)
|
observed variant
|
{l}aLYNTVATL
|
Gag(77-85)
|
observed variant
|
{l}SLYsTVATL
|
Gag(77-85)
|
observed variant
|
{c}SLYNTVAvL
|
Gag(77-85)
|
observed variant
|
{s}SLYNTVAvL
|
Gag(77-85)
|
observed variant
|
{v}SLYNTVAsL
|
Gag(77-85)
|
observed variant
|
{l}SLYNTVAaL
|
Gag(77-85)
|
observed variant
|
{v}SLYNTVAaL
|
Gag(77-85)
|
observed variant
|
SLYNTVAvL{w}
|
Gag(77-85)
|
observed variant
|
SLYNTVAvL{s}
|
Gag(77-85)
|
observed variant
|
SLYNTVAvL{r}
|
Gag(77-85)
|
observed variant
|
SLYNTVATL{w}
|
Gag(77-85)
|
observed variant
|
SLYNTVATm
|
Gag(77-85)
|
observed variant
|
aLYNTVAaL
|
Gag(77-85)
|
observed variant
|
aLYNTVAsL
|
Gag(77-85)
|
observed variant
|
SLYNaVATL
|
Gag(77-85)
|
observed variant
|
SLYNsVATL
|
Gag(77-85)
|
observed variant
|
SLYNvVATL
|
Gag(77-85)
|
observed variant
|
SLYNrVATL
|
Gag(77-85)
|
observed variant
|
SLYNlVAsL
|
Gag(77-85)
|
observed variant
|
SLYNvVAsL
|
Gag(77-85)
|
observed variant
|
gLYNTVAvL
|
Gag(77-85)
|
observed variant
|
cLYNTVAvL
|
Gag(77-85)
|
observed variant
|
gLYNTVATL
|
Gag(77-85)
|
observed variant
|
mLYNTVATL
|
Gag(77-85)
|
observed variant
|
SLYmTVATL
|
Gag(77-85)
|
observed variant
|
SLYrTVATL
|
Gag(77-85)
|
observed variant
|
SLYgTVAvL
|
Gag(77-85)
|
observed variant
|
SLYsTVAvL
|
Gag(77-85)
|
observed variant
|
SLYcTVAvL
|
Gag(77-85)
|
observed variant
|
SLYgTVAsL
|
Gag(77-85)
|
observed variant
|
SLYgTVgTL
|
Gag(77-85)
|
observed variant
|
SLYNTVgTL
|
Gag(77-85)
|
observed variant
|
SLYNTVsTL
|
Gag(77-85)
|
observed variant
|
SLYNTcATL
|
Gag(77-85)
|
observed variant
|
SiYNTVATL
|
Gag(77-85)
|
observed variant
|
StYNTVATL
|
Gag(77-85)
|
observed variant
|
ScYNTVATL
|
Gag(77-85)
|
observed variant
|
SvYNTVATL
|
Gag(77-85)
|
observed variant
|
avYNTVATL
|
Gag(77-85)
|
observed variant
|
vLYNTVATL
|
Gag(77-85)
|
observed variant
|
tLYNTVATL
|
Gag(77-85)
|
observed variant
|
rLYNTVATL
|
Gag(77-85)
|
observed variant
|
wLYNTVATL
|
Gag(77-85)
|
observed variant
|
qLYNTVATL
|
Gag(77-85)
|
observed variant
|
SLYyTVATL
|
Gag(77-85)
|
observed variant
|
SLYvTVATL
|
Gag(77-85)
|
observed variant
|
SLYfTVATL
|
Gag(77-85)
|
observed variant
|
SLYsTVATL
|
Gag(77-85)
|
observed variant
|
SLYlTVATL
|
Gag(77-85)
|
observed variant
|
SLYaTVATL
|
Gag(77-85)
|
observed variant
|
SLYtTVATL
|
Gag(77-85)
|
observed variant
|
SLYgaVATL
|
Gag(77-85)
|
observed variant
|
SLYyTVAvL
|
Gag(77-85)
|
observed variant
|
SLYslVATL
|
Gag(77-85)
|
observed variant
|
SLYNvlATL
|
Gag(77-85)
|
observed variant
|
SLYNTtATL
|
Gag(77-85)
|
observed variant
|
SLYNTlATL
|
Gag(77-85)
|
observed variant
|
SLYNTVgvL
|
Gag(77-85)
|
observed variant
|
SLYNTVAiL
|
Gag(77-85)
|
observed variant
|
SLrNTVATL
|
Gag(77-85)
|
observed variant
|
SLvNTVATL
|
Gag(77-85)
|
observed variant
|
SLwNTVATL
|
Gag(77-85)
|
observed variant
|
SLYNTVATv
|
Gag(77-85)
|
observed variant
|
SLYNTVATi
|
Gag(77-85)
|
observed variant
|
{y}SLYNTVATL
|
Gag(77-85)
|
observed variant
|
SLYNTVATL{l}
|
Gag(77-85)
|
observed variant
|
{l}SLYNvVATL
|
Gag(77-85)
|
observed variant
|
{c}SLYNlVATL
|
Gag(77-85)
|
observed variant
|
{c}SLYNvVATL
|
Gag(77-85)
|
observed variant
|
{g}SLYNTVATL
|
Gag(77-85)
|
observed variant
|
{e}SLYNTVATL
|
Gag(77-85)
|
observed variant
|
{l}gLYNTVATL
|
Gag(77-85)
|
observed variant
|
SLYNTVAvL{l}
|
Gag(77-85)
|
observed variant
|
{k}SvYNTVATL
|
Gag(77-85)
|
observed variant
|
{v}gLYNTVATL
|
Gag(77-85)
|
observed variant
|
SLYNTVATL{a}
|
Gag(77-85)
|
observed variant
|
{v}SLYaTVATL
|
Gag(77-85)
|
observed variant
|
SLYgTVATL{m}
|
Gag(77-85)
|
observed variant
|
SLYNTVAvL{a}
|
Gag(77-85)
|
observed variant
|
SLYgTVATL{a}
|
Gag(77-85)
|
observed variant
|
SLYNvVATL{w}
|
Gag(77-85)
|
observed variant
|
aLYNTVATL{l}
|
Gag(77-85)
|
observed variant
|
SLYNTVAcL{l}
|
Gag(77-85)
|
observed variant
|
SLYNTVATL{m}
|
Gag(77-85)
|
observed variant
|
{a}SLYNTVAvL
|
Gag(77-85)
|
observed variant
|
{v}SLYNTVAcL
|
Gag(77-85)
|
observed variant
|
SLYcTVATL
|
Gag(77-85)
|
non-susceptible form
|
SLYgTVATL
|
Gag(77-85)
|
observed variant
|
SLYhTVATL
|
Gag(77-85)
|
observed variant
|
SLYhlVATL
|
Gag(77-85)
|
observed variant
|
SLYNmVATL
|
Gag(77-85)
|
observed variant
|
SLYNTVvTL
|
Gag(77-85)
|
observed variant
|
cLYNTVATL
|
Gag(77-85)
|
observed variant
|
{v}SLYNTVATL{l}
|
Gag(77-85)
|
observed variant
|
{c}aLYNTVATL
|
Gag(77-85)
|
observed variant
|
{q}aLYNTVATL
|
Gag(77-85)
|
observed variant
|
{a}SLYNTVATv
|
Gag(77-85)
|
observed variant
|
SLYNTVAvL{m}
|
Gag(77-85)
|
observed variant
|
{v}SvYNTVATL
|
Gag(77-85)
|
observed variant
|
SLYgTVcTL
|
Gag(77-85)
|
observed variant
|
SLYNTVATL{r}
|
Gag(77-85)
|
observed variant
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:01, A*02:14 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:02 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:02 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:02 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A*02:02, A2 human epitope
|
SLfNTVATL
|
Gag(77-85)
|
susceptible form
|
SLYNTVATL
|
Gag(77-85)
|
A*02:05 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 transgenic mouse epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVAvL
|
Gag(77-85)
|
diminished response
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVAVL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLFNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTiATL
|
Gag(77-85)
|
non-susceptible form; susceptible form
|
SLYNTVAvL
|
Gag(77-85)
|
observed variant
|
SLfNTVAvL
|
Gag(77-85)
|
escape documented in this paper
|
SLfNTVATL
|
Gag(77-85)
|
diminished HLA binding or increased off-rate; susceptible form
|
SLfNTiATL
|
Gag(77-85)
|
diminished response
|
SLfNTiAvL
|
Gag(77-85)
|
escape documented in this paper; TCR related mutation
|
SLhNaVAvL
|
Gag(77-85)
|
susceptible form
|
SLYNTiAvL
|
Gag(77-85)
|
diminished response
|
SLYNTiAiL
|
Gag(77-85)
|
observed variant
|
SLfNTVATv
|
Gag(77-85)
|
susceptible form
|
SLYNaVATL
|
Gag(77-85)
|
susceptible form
|
SLYNlVAvL
|
Gag(77-85)
|
diminished HLA binding or increased off-rate
|
SLYNTVAif
|
Gag(77-85)
|
diminished HLA binding or increased off-rate
|
SLfNaVATL
|
Gag(77-85)
|
reversion; susceptible form
|
SLfNaVAvL
|
Gag(77-85)
|
susceptible form
|
SLfNmVATL
|
Gag(77-85)
|
susceptible form
|
SLYNTVsTL
|
Gag(77-85)
|
susceptible form
|
SLYNTitvL
|
Gag(77-85)
|
susceptible form
|
SLYNTisvL
|
Gag(77-85)
|
susceptible form
|
SLYNTVATL
|
Gag(77-85)
|
A2 human, mouse epitope
|
SLYNTVAaL
|
Gag(77-85)
|
susceptible form
|
lLYNTVATL
|
Gag(77-85)
|
susceptible form
|
SLYNTVAsL
|
Gag(77-85)
|
susceptible form
|
SLYNTpATL
|
Gag(77-85)
|
susceptible form
|
lLYNTVAaL
|
Gag(77-85)
|
susceptible form
|
lLYNTVAsL
|
Gag(77-85)
|
susceptible form
|
lLYNTVlTL
|
Gag(77-85)
|
susceptible form
|
SLYNTsAaL
|
Gag(77-85)
|
susceptible form
|
lLYNTpATL
|
Gag(77-85)
|
susceptible form
|
SLYNTpAaL
|
Gag(77-85)
|
susceptible form
|
SLYNTpAsL
|
Gag(77-85)
|
susceptible form
|
SLhNwslaL
|
Gag(77-85)
|
susceptible form
|
SLwNwplaL
|
Gag(77-85)
|
susceptible form
|
SLwNwplsL
|
Gag(77-85)
|
susceptible form
|
SLhNwplaL
|
Gag(77-85)
|
susceptible form
|
SLhNwplsL
|
Gag(77-85)
|
susceptible form
|
lLwNTslaL
|
Gag(77-85)
|
susceptible form
|
lLwNwslaL
|
Gag(77-85)
|
susceptible form
|
lLwNwslsL
|
Gag(77-85)
|
susceptible form
|
lLwNwplaL
|
Gag(77-85)
|
susceptible form
|
lLhNwslaL
|
Gag(77-85)
|
susceptible form
|
lLhNwplsL
|
Gag(77-85)
|
susceptible form
|
SLfNTVATL
|
Gag(77-85)
|
escape documented in this paper; susceptible form
|
SLfNTVAvL
|
Gag(77-85)
|
diminished response; escape documented in this paper
|
SLfNTiAvL
|
Gag(77-85)
|
escape documented in this paper; susceptible form
|
SLYNTiATL
|
Gag(77-85)
|
diminished response; susceptible form
|
SLYNTiAvL
|
Gag(77-85)
|
diminished response; susceptible form
|
SvYNTVATL
|
Gag(77-85)
|
diminished response; susceptible form
|
SLYNTVAvL
|
Gag(77-85)
|
diminished response; susceptible form
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTiATL
|
Gag(77-85)
|
susceptible form
|
SLYNTiAvL
|
Gag(77-85)
|
susceptible form
|
SLYNTVAvL
|
Gag(77-85)
|
susceptible form
|
SLfNTVATL
|
Gag(77-85)
|
susceptible form
|
SLfNTiAvL
|
Gag(77-85)
|
susceptible form
|
SLfNTVAvL
|
Gag(77-85)
|
susceptible form
|
SLfNTiATL
|
Gag(77-85)
|
susceptible form
|
SLYNsVATL
|
Gag(77-85)
|
susceptible form
|
SLYqTVATL
|
Gag(77-85)
|
susceptible form
|
SLYlTVATL
|
Gag(77-85)
|
susceptible form
|
aLYNTVATL
|
Gag(77-85)
|
susceptible form
|
SLaNTVATL
|
Gag(77-85)
|
non-susceptible form
|
SLYaTVATL
|
Gag(77-85)
|
non-susceptible form
|
SLYNTaATL
|
Gag(77-85)
|
diminished response
|
SLYNTVAaL
|
Gag(77-85)
|
diminished response
|
aLYNTaAaL
|
Gag(77-85)
|
non-susceptible form
|
SLYNvVATL
|
Gag(77-85)
|
non-susceptible form
|
SLYNlVAvL
|
Gag(77-85)
|
escape documented in this paper; TCR related mutation
|
SLYNlVAvL
|
Gag(77-85)
|
escape documented in this paper; TCR related mutation
|
SLYNaVATL
|
Gag(77-85)
|
escape documented in this paper; TCR related mutation
|
SLYNaiATL
|
Gag(77-85)
|
escape documented in this paper; TCR related mutation
|
SLYNlVAvL
|
Gag(77-85)
|
escape documented in this paper; TCR related mutation
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLfNTiATL
|
Gag(77-85)
|
escape documented in this paper
|
SLfNTiAaL
|
Gag(77-85)
|
observed variant
|
SLfNTVAvL
|
Gag(77-85)
|
escape documented in this paper
|
SLfsTVAvL
|
Gag(77-85)
|
observed variant
|
SLfNTVAvp
|
Gag(77-85)
|
observed variant
|
SLfNTiAvL
|
Gag(77-85)
|
observed variant
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLfNTVATL
|
Gag(77-85)
|
observed variant
|
SLYNTiATL
|
Gag(77-85)
|
observed variant
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 transgenic mouse epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLFNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLyNTVATL
|
Gag(77-85)
|
escape documented in this paper
|
SLyNaVATL
|
Gag(77-85)
|
escape documented in this paper
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLfNTVcvi
|
Gag(77-85)
|
diminished response; escape documented in this paper; subtype-specific non-susceptible form; TCR related mutation
|
SLfNTVATL
|
Gag(77-85)
|
diminished response; escape documented in this paper; subtype-specific non-susceptible form; TCR related mutation
|
SLfNaVATL
|
Gag(77-85)
|
diminished response; escape documented in this paper; subtype-specific non-susceptible form; TCR related mutation
|
SLaNTVATL
|
Gag(77-85)
|
diminished response; escape documented in this paper; TCR related mutation
|
SLYaTVATL
|
Gag(77-85)
|
diminished response; escape documented in this paper; TCR related mutation
|
SLYNaVATL
|
Gag(77-85)
|
diminished response; escape documented in this paper; TCR related mutation
|
SLYNTaATL
|
Gag(77-85)
|
susceptible form
|
SLYNTVAaL
|
Gag(77-85)
|
diminished response; escape documented in this paper; TCR related mutation
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVAvL
|
Gag(77-85)
|
susceptible form
|
SLfNTVAvL
|
Gag(77-85)
|
susceptible form
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLfNTVATL
|
Gag(77-85)
|
escape documented in this paper; susceptible form; TCR related mutation
|
SLYNTiATL
|
Gag(77-85)
|
escape documented in this paper
|
SLYNTiAvL
|
Gag(77-85)
|
escape documented in this paper; non-susceptible form; susceptible form; TCR related mutation
|
SLfNTiATL
|
Gag(77-85)
|
escape documented in this paper; non-susceptible form; susceptible form; TCR related mutation
|
SLYNlVAvL
|
Gag(77-85)
|
escape documented in this paper; non-susceptible form; TCR related mutation
|
SLYNTVAaL
|
Gag(77-85)
|
observed variant
|
SLYNTVATL
|
Gag(77-85)
|
A2 epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human, transgenic mouse epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 mouse epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLfNTVATL
|
Gag(77-85)
|
escape documented in this paper
|
SLYNTVAvL
|
Gag(77-85)
|
escape documented in this paper
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTIATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLfNTVATL
|
Gag(77-85)
|
observed variant
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLfNTVATL
|
Gag(77-85)
|
observed variant
|
SLfNTVAvL
|
Gag(77-85)
|
diminished HLA binding or increased off-rate
|
SLsNTVATL
|
Gag(77-85)
|
diminished HLA binding or increased off-rate
|
SsfNTVATL
|
Gag(77-85)
|
observed variant
|
SLlNTVATL
|
Gag(77-85)
|
diminished HLA binding or increased off-rate
|
SLcNTVATL
|
Gag(77-85)
|
diminished HLA binding or increased off-rate
|
SLYNTiATL
|
Gag(77-85)
|
observed variant
|
SLfNaVATL
|
Gag(77-85)
|
diminished HLA binding or increased off-rate
|
SLfNTiAvL
|
Gag(77-85)
|
diminished HLA binding or increased off-rate
|
SLfNTiATL
|
Gag(77-85)
|
observed variant
|
SLYNTiAvL
|
Gag(77-85)
|
diminished HLA binding or increased off-rate
|
SLFNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLyNTVATL
|
Gag(77-85)
|
susceptible form
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLfNTVATL
|
Gag(77-85)
|
susceptible form
|
SLYNTiATL
|
Gag(77-85)
|
susceptible form
|
SLYNTVAvL
|
Gag(77-85)
|
susceptible form
|
SLYNaVATL
|
Gag(77-85)
|
susceptible form
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLfNTVATL
|
Gag(77-85)
|
subtype-specific susceptible form
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human, transgenic mouse epitope
|
SLfNTVATL
|
Gag(77-85)
|
susceptible form
|
SLYNlVATL
|
Gag(77-85)
|
susceptible form
|
SLfNlVATL
|
Gag(77-85)
|
susceptible form
|
SiYNlVATL
|
Gag(77-85)
|
susceptible form
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 transgenic mouse epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 humanized mouse epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLFNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLFNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLfNTVATL
|
Gag(77-85)
|
observed variant
|
SLYNTVAvL
|
Gag(77-85)
|
observed variant
|
SLYNTVATi
|
Gag(77-85)
|
observed variant
|
SLfNTVATi
|
Gag(77-85)
|
observed variant
|
SLnNaiAvL
|
Gag(77-85)
|
observed variant
|
SvYNTVATL
|
Gag(77-85)
|
observed variant
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
A2, A68 human epitope
|
SLfNTiATL
|
Gag(77-85)
|
diminished response
|
SLYNTVATL
|
Gag(77-85)
|
B*57 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
C*14 human epitope
|
SLYNTVATL
|
Gag(77-85)
|
H-2d human, mouse epitope
|
SLYNTVATL
|
Gag(77-85)
|
human epitope
|
pLYNTVATL
|
Gag(77-85)
|
HLA association; TCR related mutation
|
SLfNTVATL
|
Gag(77-85)
|
HLA association; TCR related mutation
|
SLYNTiATL
|
Gag(77-85)
|
HLA association; TCR related mutation
|
SLfNTVAvL
|
Gag(77-85)
|
HLA association; TCR related mutation
|
SLfNaVAvL
|
Gag(77-85)
|
HLA association; TCR related mutation
|
SLYNTVATL
|
Gag(77-85)
|
human epitope
|
SLYNTVATL
|
Gag(77-85)
|
human epitope
|
SLYNTVATL
|
Gag(77-85)
|
human epitope
|
SLYNTVATL
|
Gag(77-85)
|
human epitope
|
SLYNTVATL
|
Gag(77-85)
|
epitope
|
SLYNTVAvL
|
Gag(77-85)
|
susceptible form
|
SLYNTiATL
|
Gag(77-85)
|
escape documented in this paper; susceptible form
|
SLYNTiAvL
|
Gag(77-85)
|
susceptible form
|
SLYNTVATL
|
Gag(77-85)
|
human epitope
|
SLYNTVATL
|
Gag(77-85)
|
human epitope
|
SLYNTVATL
|
Gag(77-85)
|
human epitope
|
SLYNTVATL
|
Gag(77-85)
|
human epitope
|
SLYNTVATL
|
Gag(77-85)
|
human epitope
|
SLYNTVATL
|
Gag(77-85)
|
human epitope
|
SLYNTVATL
|
Gag(77-85)
|
human epitope
|
SLYNTVATL
|
Gag(77-85)
|
human epitope
|
SLFNTVATL
|
Gag(77-85)
|
human epitope
|
SLYNTVATL
|
Gag(77-85)
|
human epitope
|
SLYNTVATL
|
Gag(77-85)
|
human epitope
|
SLYNTVATL
|
Gag(77-85)
|
human epitope
|
SLYNTVATL
|
Gag(77-85)
|
human epitope
|
SLYNTVATL
|
Gag(77-85)
|
human epitope
|
SLfNTiAvL
|
Gag(77-85)
|
escape documented in this paper
|
SLYNTVATL
|
Gag(77-85)
|
human epitope
|
SLYNTVATL
|
Gag(77-85)
|
human epitope
|
SLYNTVATL
|
Gag(77-85)
|
human epitope
|
SLYNTVATL
|
Gag(77-85)
|
human epitope
|
SLYNTVATLY
|
Gag(77-86)
|
A*02 human epitope
|
SLYNTVAvLY
|
Gag(77-86)
|
diminished HLA binding or increased off-rate; escape documented in this paper; susceptible form
|
SLYNTiATLY
|
Gag(77-86)
|
diminished HLA binding or increased off-rate; escape documented in this paper; susceptible form
|
SLYNTiAvLY
|
Gag(77-86)
|
diminished HLA binding or increased off-rate; escape documented in this paper; susceptible form
|
SLfNTVATLY
|
Gag(77-86)
|
diminished HLA binding or increased off-rate; escape documented in this paper; susceptible form
|
SLfNTiAvLY
|
Gag(77-86)
|
diminished HLA binding or increased off-rate; escape documented in this paper; susceptible form
|
SLfNTVAvLY
|
Gag(77-86)
|
diminished HLA binding or increased off-rate; escape documented in this paper; susceptible form
|
SLfNTiATLY
|
Gag(77-86)
|
diminished HLA binding or increased off-rate; escape documented in this paper; susceptible form
|
SLYNTVATLY
|
Gag(77-86)
|
A*02 human epitope
|
SLYNTVATLY
|
Gag(77-86)
|
A*02:01 human epitope
|
SLYNTVATLY
|
Gag(77-86)
|
A2 human epitope
|
SLYNTVATLY
|
Gag(77-86)
|
A2 human epitope
|
SLYNTVATLY
|
Gag(77-86)
|
human epitope
|
SLYNTVATLY
|
Gag(77-86)
|
human epitope
|
SLFNTVATLY
|
Gag(77-86)
|
human epitope
|
SLYNIVATLWCVH
|
Gag(77-89)
|
human epitope
|
SLYNTVATLYCVHQR
|
Gag(77-91)
|
A*02:01, A*30:02 human epitope
|
SLfNTVATLYCVHQR
|
Gag(77-91)
|
susceptible form
|
SLYNTVATLYCVHQR
|
Gag(77-91)
|
A2, B44, B60 human epitope
|
SLYNTVATLYCVHQR
|
Gag(77-91)
|
H-2d transgenic mouse epitope
|
SLYNTVATLYCVHQR
|
Gag(77-91)
|
human epitope
|
SLYNTVATLYCVHQR
|
Gag(77-91)
|
mouse epitope
|
SLYNTVATLYCVHQRIEV
|
Gag(77-94)
|
human epitope
|
SLYNTVATLYCVHQRIEV
|
Gag(77-94)
|
human epitope
|
LYNTVATL
|
Gag(78-85)
|
A*02 human epitope
|
LYNTVATL
|
Gag(78-85)
|
A24 human epitope
|
LYNTVATL
|
Gag(78-85)
|
C*14 human epitope
|
LYNTVAVL
|
Gag(78-85)
|
C*14 human epitope
|
LYNTVATL
|
Gag(78-85)
|
C*14 human epitope
|
LYNTVATL
|
Gag(78-85)
|
C*14 human epitope
|
LYNTVATL
|
Gag(78-85)
|
C*14 human epitope
|
LYNTVATL
|
Gag(78-85)
|
C*14:02 human epitope
|
LYNTVATL
|
Gag(78-85)
|
C*14:02, C*14:03 human epitope
|
LYNTVATL
|
Gag(78-85)
|
H-2d mouse epitope
|
LYNTVATL
|
Gag(78-85)
|
human epitope
|
LYNTVATLY
|
Gag(78-86)
|
A*02 human epitope
|
LYNTVAVLY
|
Gag(78-86)
|
A*29 human epitope
|
LYNTiAVLY
|
Gag(78-86)
|
observed variant
|
LfNTiAVLY
|
Gag(78-86)
|
observed variant
|
LfNTVAVLY
|
Gag(78-86)
|
observed variant
|
LYNTVATLY
|
Gag(78-86)
|
A*29 human epitope
|
LYNTVATLY
|
Gag(78-86)
|
A*29 human epitope
|
LYNTVATLY
|
Gag(78-86)
|
A*29 human epitope
|
LYNTVATLY
|
Gag(78-86)
|
A*29, B*44 epitope
|
LYNTVATLY
|
Gag(78-86)
|
A29 human epitope
|
LYNTVATLY
|
Gag(78-86)
|
A*29:02 human epitope
|
LYNTVATLY
|
Gag(78-86)
|
A*29:02 human epitope
|
LYNTIATLY
|
Gag(78-86)
|
A*29:02 human epitope
|
LFNTVATLY
|
Gag(78-86)
|
A*29:02 human epitope
|
LYNTVATLY
|
Gag(78-86)
|
A*29:02, B*44:03 human epitope
|
LYNTVATLY
|
Gag(78-86)
|
A*29:02, B*44:03 human epitope
|
LYNTVATLY
|
Gag(78-86)
|
A*30 human epitope
|
LYNTVATLY
|
Gag(78-86)
|
B*44:03 human epitope
|
LYNTVATLY
|
Gag(78-86)
|
B*81 human epitope
|
LYNTVATLY
|
Gag(78-86)
|
C*14 human epitope
|
LYNTVATLY
|
Gag(78-86)
|
human epitope
|
LYNTVATLY
|
Gag(78-86)
|
human epitope
|
LYNTVATLY
|
Gag(78-86)
|
human epitope
|
LYNTVATLY
|
Gag(78-86)
|
human epitope
|
LFNTVATLY
|
Gag(78-86)
|
human epitope
|
LyNTVATLY
|
Gag(78-86)
|
observed variant
|
LYNTVATLY
|
Gag(78-86)
|
human epitope
|
LFNTVATLYCV
|
Gag(78-88)
|
A*02 human epitope
|
LYNTVATLYCVHQRI
|
Gag(78-92)
|
human epitope
|
YNIVATLWCVHQ
|
Gag(79-90)
|
human epitope
|
YNtVATLWCVHQ
|
Gag(79-90)
|
subtype-specific susceptible form
|
YNTVATLYCVHQRI
|
Gag(79-92)
|
human epitope
|
NTVATLYCV
|
Gag(80-88)
|
A2 human, transgenic mouse epitope
|
NTVATLYCV
|
Gag(80-88)
|
A2 human epitope
|
NaiAvLYCV
|
Gag(80-88)
|
observed variant
|
NTVAvLYCV
|
Gag(80-88)
|
observed variant
|
NTVATiYCV
|
Gag(80-88)
|
observed variant
|
NTVATLYCV
|
Gag(80-88)
|
observed variant
|
NTVATLYCV
|
Gag(80-88)
|
A2 human epitope
|
TVATLYCVH
|
Gag(81-89)
|
C*12:02 human epitope
|
TVATLYCVH
|
Gag(81-89)
|
human epitope
|
TVATLYCVHQRIEVK
|
Gag(81-95)
|
mouse epitope
|
TVATLYCVHQRIEVKDTKEA
|
Gag(81-100)
|
human epitope
|
VATLYCVHQ
|
Gag(82-90)
|
human epitope
|
IATLWCVHQR
|
Gag(82-91)
|
A*11 human epitope
|
IAVLYCVHQR
|
Gag(82-91)
|
A*11 epitope
|
IvVLYCVHQR
|
Gag(82-91)
|
observed variant
|
IATLWCVHQR
|
Gag(82-91)
|
A11 human epitope
|
IATLWCVHQR
|
Gag(82-91)
|
human epitope
|
VATLYCVHQRI
|
Gag(82-92)
|
A*11 human epitope
|
VvTLYCVHQRI
|
Gag(82-92)
|
susceptible form
|
VATLYCVHQRIEVK
|
Gag(82-95)
|
human epitope
|
VAVLYCVHQRIDVKD
|
Gag(82-96)
|
human epitope
|
VAtLYCVHQkIeVKD
|
Gag(82-96)
|
susceptible form
|
VATLYCVHQKIEVKD
|
Gag(82-96)
|
human epitope
|
VAvLYCVHQrIdVKD
|
Gag(82-96)
|
susceptible form
|
VATLYCVHQRIDVKDTK
|
Gag(82-98)
|
human epitope
|
ATLYCVHQR
|
Gag(83-91)
|
A*11 human epitope
|
AVLYCVHQR
|
Gag(83-91)
|
A11 human epitope
|
ATLYCVHQR
|
Gag(83-91)
|
A*11:01 human epitope
|
ATLYCVHQK
|
Gag(83-91)
|
human epitope
|
ATLYCVHQK
|
Gag(83-91)
|
human epitope
|
ATLYCVHQK
|
Gag(83-91)
|
human epitope
|
ATLYCVHQR
|
Gag(83-91)
|
human epitope
|
{A}TLYCVHQK{IE}
|
Gag(83-93)
|
A*11 human epitope
|
ATLWCVHQRIDI
|
Gag(83-94)
|
human epitope
|
ATLWCVHQRIev
|
Gag(83-94)
|
subtype-specific susceptible form
|
ATLYCVHEKIEVRDTKEALDK
|
Gag(83-103)
|
human epitope
|
TLYCVHQK
|
Gag(84-91)
|
A*11 human epitope
|
TLYCVHQR
|
Gag(84-91)
|
A11 human epitope
|
TLYCVHQk
|
Gag(84-91)
|
susceptible form
|
TLYCVHQq
|
Gag(84-91)
|
diminished response
|
TLYCVHeR
|
Gag(84-91)
|
escape documented in this paper
|
TLYCVHQR
|
Gag(84-91)
|
A*11:01 human epitope
|
TLYCVHQk
|
Gag(84-91)
|
susceptible form
|
TLwCVHQR
|
Gag(84-91)
|
observed variant
|
TLYCVHeR
|
Gag(84-91)
|
observed variant
|
TLYCVHQK
|
Gag(84-91)
|
A*11:01 human epitope
|
VLYCVHQG
|
Gag(84-91)
|
A*11:01 human epitope
|
TMYCVHQK
|
Gag(84-91)
|
A*11:01 human epitope
|
TlYCVHQr
|
Gag(84-91)
|
diminished response; escape documented in this paper; non-susceptible form
|
vlYCVHQr
|
Gag(84-91)
|
diminished response; escape documented in this paper; non-susceptible form
|
TlYCVHQK
|
Gag(84-91)
|
diminished response; escape documented in this paper; non-susceptible form; susceptible form
|
TLYCVHQK
|
Gag(84-91)
|
human epitope
|
TLYCVHQK
|
Gag(84-91)
|
human epitope
|
TLYCVHQRI
|
Gag(84-92)
|
A*11 epitope
|
TLYCVHQRI
|
Gag(84-92)
|
A*11 human epitope
|
TLYCVHQRI
|
Gag(84-92)
|
A*11 human epitope
|
TLYCVHQRI
|
Gag(84-92)
|
A11 human epitope
|
TLYCVHQRI
|
Gag(84-92)
|
A11 human epitope
|
TLYCVHQRI
|
Gag(84-92)
|
A11 human epitope
|
TLYCVHQRI
|
Gag(84-92)
|
A11 human epitope
|
TLYCVHQRI
|
Gag(84-92)
|
A11 human epitope
|
TLYCVHQRI
|
Gag(84-92)
|
A11 human epitope
|
TLYCVHQRI
|
Gag(84-92)
|
A11 human epitope
|
TLYCVHQKI
|
Gag(84-92)
|
A*11:03 human epitope
|
VLYCVHQRI
|
Gag(84-92)
|
A2 human epitope
|
TLYCVHQRI
|
Gag(84-92)
|
A*32 human epitope
|
TLYCVHQRI
|
Gag(84-92)
|
B*13 human epitope
|
TLYCVHQRI
|
Gag(84-92)
|
C*12 human epitope
|
TLYCVHQRI
|
Gag(84-92)
|
human epitope
|
LYCVHQKI
|
Gag(85-92)
|
A24 human epitope
|
LYCVHQRI
|
Gag(85-92)
|
H-2d mouse epitope
|
LYCVHQRIEVK
|
Gag(85-95)
|
human epitope
|
LYCVHQRIEVK
|
Gag(85-95)
|
human epitope
|
LYwVHQRIEVK
|
Gag(85-95)
|
diminished response
|
LYCVHQRmEVK
|
Gag(85-95)
|
diminished response
|
LYCVHrkIdVK
|
Gag(85-95)
|
observed variant
|